Your browser doesn't support javascript.
loading
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.
Rayson, Daniel; Lupichuk, Sasha; Potvin, Kylea; Dent, Susan; Shenkier, Tamara; Dhesy-Thind, Sukhbinder; Ellard, Susan L; Prady, Catherine; Salim, Muhammad; Farmer, Patricia; Allo, Ghasson; Tsao, Ming-Sound; Allan, Alison; Ludkovski, Olga; Bonomi, Maria; Tu, Dongsheng; Hagerman, Linda; Goodwin, Rachel; Eisenhauer, Elizabeth; Bradbury, Penelope.
Afiliación
  • Rayson D; Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Room 457A, 1276 South Park Street, Bethune Building, Halifax, NS, B3H 2Y9, Canada. daniel.rayson@nshealth.ca.
  • Lupichuk S; Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Potvin K; London Regional Cancer Program, London, ON, UK.
  • Dent S; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Shenkier T; BCCA-Vancouver Cancer Centre, Vancouver, BC, Canada.
  • Dhesy-Thind S; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada.
  • Ellard SL; BCCA-Cancer Centre for the Southern Interior, Kelowna, BC, Canada.
  • Prady C; Hopital Charles LeMoyne, Greenfield Park, QC, Canada.
  • Salim M; Allan Blair Cancer Centre, Regina, SK, Canada.
  • Farmer P; Queen's University, Kingston General Hospital, Kingston, ON, Canada.
  • Allo G; Henry Ford Health System, Detroit, MI, USA.
  • Tsao MS; University Health Network-OCI/Princess Margaret Hospital, Toronto, ON, Canada.
  • Allan A; London Regional Cancer Program, London, ON, UK.
  • Ludkovski O; University Health Network-OCI/Princess Margaret Hospital, Toronto, ON, Canada.
  • Bonomi M; Canadian Cancer Trials Group (CCTG), Queen's University, Kingston, CA, Canada.
  • Tu D; Canadian Cancer Trials Group (CCTG), Queen's University, Kingston, CA, Canada.
  • Hagerman L; Canadian Cancer Trials Group (CCTG), Queen's University, Kingston, CA, Canada.
  • Goodwin R; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Eisenhauer E; Canadian Cancer Trials Group (CCTG), Queen's University, Kingston, CA, Canada.
  • Bradbury P; University Health Network-OCI/Princess Margaret Hospital, Toronto, ON, Canada.
Breast Cancer Res Treat ; 157(1): 109-16, 2016 05.
Article en En | MEDLINE | ID: mdl-27116183
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 / Neoplasias de la Mama Triple Negativas / Anilidas / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Breast Cancer Res Treat Año: 2016 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 / Neoplasias de la Mama Triple Negativas / Anilidas / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Breast Cancer Res Treat Año: 2016 Tipo del documento: Article País de afiliación: Canadá